Saluda Medical opens full US release of its closed-loop surgical paddle lead
The CAP24 lead lets surgeons use Saluda's Evoke closed-loop spinal cord stimulation with a paddle electrode.
Saluda Medical announced on October 6 the full US commercial release of its CAP24 surgical paddle lead, after a limited release at selected centers. The FDA approved CAP24 earlier in 2026, and the company says it is the only FDA-approved surgical paddle lead for closed-loop therapy. It works with Saluda’s Evoke spinal cord stimulation system, which measures the spinal cord’s response to each pulse and adjusts the next one to keep the dose steady.
Paddle leads are placed surgically rather than through a needle. Saluda says surgical placements make up about 30% of US spinal cord stimulator implants, a segment its closed-loop therapy previously could not reach.
Learn more: Closed-loop system · Saluda Medical